12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements in Thursday's pre-market session. Notable gainers include Autonomix Medical, Tenon Medical, and Alphatec Holdings, while Matinas BioPharma and Equillium saw substantial declines.
October 31, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Autonomix Medical shares surged by 50.8% in pre-market trading, indicating strong investor interest.
The significant price increase suggests positive sentiment or news, likely attracting more investor attention.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Alphatec Holdings shares increased by 24.73% following the release of Q3 earnings.
The rise in stock price is likely due to positive Q3 earnings, suggesting strong financial performance.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Madrigal Pharmaceuticals shares rose by 13.46% following the release of Q3 earnings.
The increase in stock price is likely due to favorable Q3 earnings, suggesting strong performance.
CONFIDENCE 85
IMPORTANCE 55
RELEVANCE 65
POSITIVE IMPACT
Envista Holdings stock increased by 14.4% after Q3 earnings were announced.
The stock's rise is likely driven by positive Q3 earnings, indicating good financial health.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Tenon Medical shares rose by 34.96% in pre-market trading, reflecting positive market sentiment.
The substantial price increase indicates a positive outlook or news, potentially driving further interest.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
CalciMedica stock declined by 19.8% in pre-market trading.
The decrease in stock price indicates negative sentiment or news, impacting investor confidence.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Compass Pathways shares fell 16.81% following the release of Q3 earnings.
The decline in stock price is likely due to unfavorable Q3 earnings, impacting investor sentiment.
CONFIDENCE 85
IMPORTANCE 55
RELEVANCE 65
NEGATIVE IMPACT
Ensysce Biosciences shares decreased by 21.34% in pre-market trading.
The decline suggests negative sentiment or news, potentially affecting investor interest.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Equillium stock decreased by 42.76% in pre-market trading, reflecting negative market sentiment.
The significant drop indicates negative sentiment or news, likely impacting investor confidence.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Matinas BioPharma shares fell 51.8% in pre-market trading, indicating negative sentiment.
The sharp decline suggests negative news or sentiment, potentially deterring investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Psyence Biomedical shares declined by 19.15% in pre-market trading.
The decline suggests negative sentiment or news, potentially affecting investor interest.
CONFIDENCE 75
IMPORTANCE 45
RELEVANCE 55